Public Charity

ALZHEIMER'S DISEASE INTERNATIONAL C/O WIPFLI LLP

ALZHEIMER'S DISEASE INTERNATIONAL C/O WIPFLI LLP is a nonprofit organization categorized as Public Charity based in LINCOLNSHIRE, IL. Its most recent IRS filing (2025) reports revenue of $1.9M, expenses of $2.3M, total assets of $716K. Imperigo tracks 6 reported grant relationships connected to this organization totaling approximately $184K.

EIN: 363366783 LINCOLNSHIRE, IL Latest filing: 2025
Total Revenue$1.9M
Total Expenses$2.3M
Total Assets$716K
Grant Records6
Funding Total$184K
Filing Years2021–2025

Mission

ADI'S VISION IS RISK REDUCTION, TIMELY DIAGNOSIS, CARE AND INCLUSION TODAY, AND CURE TOMORROW. ADI'S MISSION IS TO STRENGTHEN AND SUPPORT ALZHEIMER AND DEMENTIA ASSOCIATIONS, TO RAISE AWARENESS AND LOWER STIGMA ABOUT DEMENTIA WORLDWIDE, TO MAKE DEMENTIA A GLOBAL HEALTH PRIORITY, TO SUPPORT AND EMPOWER PEOPLE LIVING WITH DEMENTIA AND THEIR CARE PARTNERS, AND TO INCREASE INVESTMENT AND INNOVATION IN DEMENTIA RESEARCH.

Where $100 goes at Alzheimer's Disease International C/O Wipfli LLP

How Alzheimer's Disease International C/O Wipfli LLP divides every $100 it spends, from its own Form 990 filings, averaged across 9 years.

$74 Programs the work itself
$17 Management running the organization
$9 Fundraising raising the next dollar

Inside the $74 for programs

$35
World alzheimer's month 2024 saw 111 countries participating, 35 million social media impressions of the hashtags and 300 pieces of traditional media coverage
48% of program spending
$22
A three-day alzheimer university was held in april 2025 in london
29% of program spending
$17
Adi continued to participate in research projects and collaborations, including a memorandum of understanding with the world-wide fingers project, forming connections between global brain health institute (gbhi) fellows…
23% of program spending

Plus 1 more program. Cost per person served and the full program breakdown are on the full profile.

Share on LinkedIn Share on Facebook
Add this to your website

Source: Form 990 filings with the IRS, latest fiscal year 2025. Shares are from the organization's reported expenses. Data by Imperigo; not affiliated with the IRS.

Officers & Directors

DIRECTOR Alireza Atri
DIRECTOR Ameenah Sorefan
DEPUTY CEO Christopher Lynch
CHAIR Dale Goldhawk
DIRECTOR Emily Ong
DIRECTOR Huali Wang

Officer compensation and complete director data available with membership.

Top Grant Purposes

Health & Medicine
$110,000 3 grants
General Support
$74,272 3 grants

Financial Trends

Year Revenue Expenses Assets
2025 $1.9M $2.3M $716K
2024 $2.2M $2.8M $1.1M
2023 $1.7M $1.9M $1.6M
2022 $1.5M $1.6M $1.5M
2021 $2.5M $2.1M $1.6M

Between 2021 and 2025, reported annual revenue declined from $2.5M to $1.9M (-22%), with total assets most recently reported at $716K.

Interactive year-over-year charts and full filing details available with membership.

See the full picture for ALZHEIMER'S DISEASE INTERNATIONAL C/O WIPFLI LLP

Complete financials, all 6 grant records, officer compensation, year-over-year trend charts, a geographic grant map, and data exports — across 880,000+ organizations.

Full Financial History Complete Grant Activity Officer Compensation Year-over-Year Charts Geographic Grant Map Data Exports
7-day free trial Cancel any time